Burcu Anil Kirmizitas

Burcu Anil Kirmizitas is an accomplished professional in the field of biochemistry and biophysics with extensive experience in scientific communication and research. Currently serving as Senior Scientific Team Lead at Remedica Communications since August 2022, Kirmizitas has previously held the position of Principal Medical Writer and Senior Medical Writer at M3 EU from October 2019 to August 2022. Other notable roles include Medical Writer at Ogilvy Health UK, Senior Medical Writer at M3 EU, and Postdoctoral Research Associate at the University of Oxford, where Kirmizitas led significant research projects in chromatin, epigenetics, and anticancer drug design. Academic qualifications include a Ph.D. from Stony Brook University and a B.S. in Chemistry from Bilkent University.